Data / Form D filings / NanoVibronix, Inc.
NanoVibronix, Inc.: Form D filings
NanoVibronix, Inc., a biotechnology company in Elmsford, NY, filed 17 Form D notices with the SEC between 2011 and 2023. The latest, on September 13, 2023, reports $13.5 million sold of a $13.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 525 EXECUTIVE BLVD., Elmsford, NY, 10523
- Phone
- (914) 233-3004
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1326706
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | New notice | $13,546,513 | $13,546,513 | 1 | Aug 30, 2023 | sec.gov | |
| Jun 29, 2022 | New notice | $250,000 | $250,000 | 1 | Jun 14, 2022 | sec.gov | |
| Feb 5, 2021 | New notice | $1,254,206 | $1,254,206 | 3 | Jan 22, 2021 | sec.gov | |
| Dec 11, 2020 | New notice | $6,562,500 | $6,562,500 | 13 | Dec 2, 2020 | sec.gov | |
| Aug 18, 2020 | New notice | Indefinite | $0 | 1 | Aug 5, 2020 | sec.gov | |
| Jul 6, 2020 | New notice | $450,000 | $450,000 | 1 | Jun 22, 2020 | sec.gov | |
| Apr 3, 2017 | New notice | $500,000 | $100,000 | $400,000 | 1 | Mar 23, 2017 | sec.gov |
| Apr 3, 2017 | New notice | $250,000 | $250,000 | 3 | Mar 1, 2017 | sec.gov | |
| May 1, 2015 | New notice | Indefinite | $257,000 | 1 | Apr 7, 2015 | sec.gov | |
| Mar 16, 2015 | Amendment | Indefinite | $1,500,000 | 2 | Feb 5, 2013 | sec.gov | |
| Mar 16, 2015 | New notice | Indefinite | $1,355,279 | 28 | Mar 1, 2009 | sec.gov | |
| Mar 16, 2015 | New notice | Indefinite | $2,500,023 | 15 | Feb 6, 2005 | sec.gov | |
| Mar 16, 2015 | New notice | Indefinite | $218,269 | 11 | Nov 1, 2004 | sec.gov | |
| Mar 16, 2015 | New notice | Indefinite | $908,653 | 27 | Nov 4, 2003 | sec.gov | |
| Mar 16, 2015 | New notice | Indefinite | $3,150,000 | 7 | Jan 29, 2015 | sec.gov | |
| Feb 19, 2013 | New notice | $100,000 | $100,000 | 2 | Feb 5, 2013 | sec.gov | |
| Dec 6, 2011 | New notice | $1,000,000 | $1,000,000 | 17 | Nov 21, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Brown | Executive Officer | |
| Michael Ferguson | Director | |
| Maria R. Schroeder | Director | |
| Christopher Fashek | Director | |
| Harold Jacob | Director | |
| Martin R. Goldstein | Director | |
| Brian Murphy | Executive Officer, Director | |
| Thomas R. Mika | Director | |
| Aurora R. Cassirer | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 11, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NanoVibronix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.